Publications Office of the EU
Dodávky léků – BIMZELX 2024 - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Dodávky léků – BIMZELX 2024

  • Published
    26/11/2024
  • Deadline
    06/01/2025
  • Opening of tenders
    06/01/2025
  • Awarded
    12/03/2025
  • Today
    10/07/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Revmatologický ústav
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: CZ010 Hlavní město Praha
Business sector (Main CPV)
33652000 Antineoplastic and immunomodulating agents
Total estimated contract value (excluding VAT)
55,787,000.00 CZK
Total final contract value (excluding VAT)
55,787,000.00 CZK
Tender reference number
017889/REVUS-296019
Description

Předmětem plnění jsou průběžné dodávky dle Přílohy č. 1 Kupní smlouvy – Cenová nabídka, v rozsahu a v souladu se zadávacími podmínkami jsou dodávky léčivého přípravku bimekizumab – L04AC21

Submission Method
Electronic via:
https://nen.nipez.cz/profil/revmatologickyustav
Tenders may be submitted
Electronic submission: required
https://nen.nipez.cz/profil/revmatologickyustav
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
06/01/2025 16:30
Award method
Základní hodnotící kriteria
Estimated value
55,787,000.00 CZK
Final contracted value
55,787,000.00 CZK
Award of contract
Official name: Alliance Healthcare s.r.o.
Postal address:
Town: Praha
Postal code: 10800
Country:
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.